Rx for Lung Cancer- Sweatman Flashcards

1
Q

Name 3 mechanisms of resistance to TKIs

A

1) Drug binding site mutation (highly conserved ATP binding site)
2) Compensatory Tyrosine phosphorylation by MET
3) MET assumes an independent role in the proliferative signaling process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 2 common downstream mutations in the EGFR/Tyrosine Kinase complex pathway?

A

Constitutive activation of KRAS or BRAF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What effect does downstream mutation have on drug therapy?

A

It renders it useless

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the effect of the EML4-ALK oncogene?

A

Activation of MEK/ERK, subsequent proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Who is the EML4-ALK mutation seen in?

A

Non-smokers and those with adenocarcinomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the mechanism for VEGF release?

A

Hypoxia is sensed by the cell–> induces HIF-1–>HIF-1 translates to the nucleus–>VEGF is transcribed–>Angiogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What TKI is used against EML4-ALK?

A

Crizotinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What TKI is used against EGFR?

A

Erlotinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the gold standard CONVENTIONAL chemo treatment for SCLC?

A

Etoposide + cisplatin or carboplatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When is Erlotinib first line therapy?

A

Treatment of locally advanced or metastatic NSCLC after failure of at least one prior chemo regimen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Mechanism of 6-Mercaptopurine, 6-Thioguanine, and Methotrexate therapy?

A

Inhibits purine ring synthesis; the first 2 interrupt elongation after incorporation into the strand; MTX is a DHFR antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Mechanism of Hydroxyurea?

A

Inhibits ribonucleotide reductase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Mechanism of 5-Fluorouracil?

A

Inhibits dTMP synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mechanism of Cytarabine?

A

Inhibits DNA synthesis (antimetabolite)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mechanism of Bleomycin?

A

Acts as molecular scissors to cut DNA strands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Mechanism of the Anthracyclines?

A

Intercalate DNA; also produces free radicals (where the cardiomyopathy comes from)

17
Q

Mechanism of the alkylating agents, Nitrosureas, and Platinum drugs?

A

Cross-link DNA

18
Q

Mechanism of L-aspariginase?

A

Inhibits protein synthesis

19
Q

Mechanism of Taxanes and Vincas?

A

Inhibit microtubule function; Taxanes stabilize and Vincas prevent formation

20
Q

Unique toxicities of the platinum drugs?

A

Ototoxicity and Nephrotoxicity

21
Q

Unique toxicity of cyclophosphamide and ifosfamide? What is given with it to prevent this?

A

Hemorrhagic cystitis (more so cyclophosphamide); mesna protects the bladder

22
Q

Unique toxicities seen in the taxanes and vincas? What clinical finding helps you diagnose this?

A

Peripheral neuropathy; loss of deep tendon reflex

23
Q

Unique toxicity of the anthracylcines (doxorubicin, daunorubicin, and idrarubicin)? What is given to protect against it?

A

Cardiomyopathy–>CHF; co-administer with dexrazoxane

24
Q

What are some downsides to oral therapy (TKIs)?

A

Interactions with CYP, P-gp efflux pumps, first-pass metabolism, and drug drug interactions

25
Q

Are TKIs used for NSCLC or SCLC?

A

NSCLC

26
Q

Name the common ADEs of TKIs

A

1) EGFR antagonists cause skin rash
2) All TKIs cause GI symptoms like nausea, vomiting, diarrhea (EGFR important in maintenance of GI cells)
3) Endocrine dysfunction and QT prolongation

27
Q

Why are there so many ADEs associated with TKIs?

A

The target is very nonspecific and it plays an important homeostatic role in multiple tissues throughout the body

28
Q

What is the definition of a pharmacodynamic change? what are some examples?

A

A change in the level of drug in the body; protein binding, efflux pumps

29
Q

What is the definition of pharmacokinetic change?

A

Alteration of the molecular target

30
Q

What is the role of CTLA-4?

A

plays an important role in T cell activation at initial antigen presentation

31
Q

What is PD1?

A

Don’t you mean PD-L1? What a fucking douche

32
Q

What is the significance of PD-L1 expression by cancer cells?

A

It binds T-cells and tells the lymphocyte it is a friendly cell; evades the immune system

33
Q

What is Nivolumab?

A

A recently approved drug; only for metastatic disease after platinum drug based therapy

34
Q

Mechanism of action of Bevacizumab?

A

Inhibits VEGF–> inhibits angiogenesis

35
Q

What are a couple life threatening toxicites of Bevacizumab?

A

Thromboembolism, fistula formation, hemorrhage

36
Q

Why does Bevacizumab cause nephrotoxicity?

A

Because VEGF plays an important homeostatic role in maintaing the glomerular basement membrane

37
Q

Why is bevacizumab not recommended for treatment of squamous cell lung carcinoma?

A

Because it commonly causes fatal hemorrhage